IMPROVEMENT IN EXERCISE CAPACITY AND EXERCISE HEMODYNAMICS 3 MONTHS AFTER DOUBLE-BALLOON, CATHETER BALLOON VALVULOPLASTY TREATMENT OF PATIENTS WITH SYMPTOMATIC MITRAL-STENOSIS
IMPROVEMENT IN EXERCISE CAPACITY AND EXERCISE HEMODYNAMICS 3 MONTHS AFTER DOUBLE-BALLOON, CATHETER BALLOON VALVULOPLASTY TREATMENT OF PATIENTS WITH SYMPTOMATIC MITRAL-STENOSIS
复制标题
DOI:
10.1161/01.cir.77.5.1013
复制
发表时间:
1988-05-01
期刊:
影响因子:
37.8
通讯作者:
RAHIMTOOLA, SH
中科院分区:
文献类型:
--
作者:
MCKAY, CR;KAWANISHI, DT;RAHIMTOOLA, SH
Clinical status, exercise treadmill performance, and hemodynamics were determined in 24 patients with symptomatic mitral stenosis before catheter balloon valvuloplasty (CBV) and at 3 months follow-up. Hemodynamic deterninations at rest showed that mitral CBV performed by the double-balloon technique resulted in significant immediate decreases in mean pulmonary arterial wedge pressure (28 .+-. 7 to 16 .+-. 5 mm Hg, p < .01), mean pulmonary arterial pressure (41 .+-. 11 to 33 .+-. 10 mm Hg,p < .05), and mitral valve gradient (16 .+-. 7 to 6 .+-. 3 mm Hg, p < .01), and significant increases in cardiac output (4.3 .+-. 1.1 to 5.0 .+-. 1.4 liters/min, p < .01). Mitral valve area increased from 1.0 .+-. 0.3 to 2.2 .+-. 0.72 (p < .01). The mitral valve area was unchanged (2.0 .+-. 0.7 cm2, p = NS) at 3 months. The lower pulmonary arterial wedge pressure, pulmonary arterial pressure, and mitral valve gradient persisted at 3 month follow-up catheterization. Clinical examinations showed that before CBV, 21 of 24 patients were in New York Heart Association functional class III or IV; 3 months after CBV, 22 patients were in class I or II. Before CBV, the mean exercise treadmill time was 5.9 .+-. 3.2 min and it had increased to 9.8 .+-. 2.9 min (P < .01) by the 3 month follow-up. Comparisons of hemodynamic determinations at the same exercise workload and duration before CBV and 3 months after CBV showed that despite similar heart rates and increased cardiac outputs (5.9 .+-. 1.7 vs 6.9 .+-. 1.5 liters/min, p < .01), there were significant decreases in the mean pulmonary arterial wedge pressure (42 .+-. 10 vs 28 .+-. 10 mm Hg, p < .01), mean pulmonary arterial pressure (61 .+-. 17 vs 42 .+-. 12 mm Hg, p < .01), and mitral valve gradient (27 .+-. 8 vs 14 .+-. 7 mm Hg, p < .01). Comparisons of hemodynamic determinations at symptom-limited supine bicycle exercise before and 3 months after CBV showed that the exercise time (9.1 .+-. 3.2 vs 17.1 .+-. 3.7 min, p < .01) and workload (43 .+-. 18.7 vs 58.9 .+-. 18.2 W, p < .01) both increased. Despite significant increases in heart rate (116 .+-. 23 vs 127 .+-. 20 beats/min,p < .01) and cardiac output (5.9 .+-. 1.7 vs 8.0 .+-. 1.5 liters/min, p < .01), mean pulmonary arterial pressure (61 .+-. 17 vs 42 .+-. 11 mm Hg, p < .01), and mitral gradient (27 .+-. 8 vs 16 .+-. 5 mm Hg, p < .01) were significant. Comparisons of hemodynamic determinations at the two exercise levels 3 months after CBV(Post-CBV:Exl vs Post-CBV:Ex2) also demonstrated significant increases in heart rate (119 .+-. 25 vs 127 .+-. 20 beats/min, p < .01) and cardiac output (6.9 .+-. 1.5 vs 8.0 .+-. 1.5 liters/min, p < .01) associated with small changes in the pulmonary arterial wedge pressure (28 .+-. 10 vs 28 .+-. 9 mm Hg, p = NS) and pulmonary arterial pressure (42 .+-. 12 vs 42 .+-. 11 mm Hg, p = NS). We conclude that mitral CBV by the double-balloon technique resulted in increased mitral valve areas that persisted at 3 month follow-up and were associated with reduced symptoms, increased exercise treadmill time, increased supine exercise bicycle performance, and a significant improvement in hemodynamics both at rest and exercise; the latter provides a physiologic explanation for the observed clinical and treadmill improvement.